JP2025506454A5 - - Google Patents
Info
- Publication number
- JP2025506454A5 JP2025506454A5 JP2024547103A JP2024547103A JP2025506454A5 JP 2025506454 A5 JP2025506454 A5 JP 2025506454A5 JP 2024547103 A JP2024547103 A JP 2024547103A JP 2024547103 A JP2024547103 A JP 2024547103A JP 2025506454 A5 JP2025506454 A5 JP 2025506454A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- temperature
- formula
- degrees
- solvent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263267734P | 2022-02-09 | 2022-02-09 | |
| US63/267,734 | 2022-02-09 | ||
| PCT/CA2023/050163 WO2023150874A1 (en) | 2022-02-09 | 2023-02-08 | Crystalline forms of n-{[(s)-{[3-(4-chlorophenyl)-4-phenyl-4,5-dihydro-1h-pyrazol-1-yl][4-(trifluoromethyl)benzene sulfonamido]methylidene}amino] methanimidoyl}acetamide |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025506454A JP2025506454A (ja) | 2025-03-11 |
| JP2025506454A5 true JP2025506454A5 (https=) | 2026-01-21 |
Family
ID=87563337
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024547103A Pending JP2025506454A (ja) | 2022-02-09 | 2023-02-08 | Ｎ－｛［（ｓ）－｛［３－（４－クロロフェニル）－４－フェニル－４，５－ジヒドロ－１ｈ－ピラゾール－１－イル］［４－（トリフルオロメチル）ベンゼンスルホンアミド］メチリデン｝アミノ］メタンイミドイル｝アセトアミドの結晶形態 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20250188038A1 (https=) |
| EP (1) | EP4476200A4 (https=) |
| JP (1) | JP2025506454A (https=) |
| CN (1) | CN119032082A (https=) |
| WO (1) | WO2023150874A1 (https=) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016196646A1 (en) * | 2015-06-04 | 2016-12-08 | The United States Of America, As Represented By The Secretary, Departmet Of Health & Human Services | Cannabinoid receptor mediating compounds |
-
2023
- 2023-02-08 WO PCT/CA2023/050163 patent/WO2023150874A1/en not_active Ceased
- 2023-02-08 US US18/836,231 patent/US20250188038A1/en active Pending
- 2023-02-08 JP JP2024547103A patent/JP2025506454A/ja active Pending
- 2023-02-08 EP EP23752186.9A patent/EP4476200A4/en active Pending
- 2023-02-08 CN CN202380020969.2A patent/CN119032082A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7181896B2 (ja) | オメカムティブメカルビルの合成 | |
| CN1227233C (zh) | 纯晶形的5－氯－3－(4－甲磺酰基苯基)－6′－甲基－[2,3′]联吡啶及其合成方法 | |
| JP2009537603A (ja) | ５−アミノ−３−（２’，３’−ジ−Ｏ−アセチル−ベータ−Ｄ−リボフラノシル）−３Ｈ−チアゾロ［４，５−ｄ］ピリミジン−２−オンのマレイン酸塩のＡ型及びＢ型結晶形 | |
| CN1612863A (zh) | 氘代的取代的吡唑基－苯磺酰胺以及包含该化合物的药物组合物 | |
| JP2011508767A (ja) | ボセンタン、その多形形態及びその塩の合成方法 | |
| WO2021196949A1 (zh) | 一种glp-1受体激动剂的晶型a及其制备方法 | |
| JP6937322B2 (ja) | 置換ピペリジン化合物の塩 | |
| JP2025148397A5 (https=) | ||
| WO2024017170A1 (zh) | S-(-)-尼古丁(-)-二苯甲酚-l-酒石酸盐晶型、制备方法及应用 | |
| CN1411373A (zh) | 制备来氟米特的新方法和新晶形的来氟米特 | |
| JP2025506454A5 (https=) | ||
| JP2023517729A5 (https=) | ||
| EP2626355A1 (en) | Process for the preparation of nilotinib hydrochloride | |
| WO2017092702A1 (zh) | 奥贝胆酸晶型ⅱ及其制备方法和用途 | |
| CN107286070B (zh) | (r)-2-(2,5-二氟苯基)吡咯烷的合成方法及中间体 | |
| US10947185B2 (en) | Crystal form of dezocine and preparation method therefor | |
| EP2155698A1 (en) | Novel thermodynamically stable polymorphic form-l of letrozole | |
| EP3279182B1 (en) | Acetylsalicylic acid derivative crystal and preparation method and use thereof | |
| CN1496350A (zh) | 制备纯二水合昂丹司琼盐酸盐的改进方法 | |
| CN115093399A (zh) | 一种抗痛风药物托匹司他的制备方法 | |
| JP2023523165A5 (https=) | ||
| CN109689620B (zh) | 拆分巴氯芬盐的方法 | |
| CN114105872A (zh) | 一种用于制备盐酸丙卡特罗的中间体及其制备方法 | |
| US20060241311A1 (en) | Noval polymorphs of atovaquone and process of | |
| CN1678606A (zh) | 新颖结晶 |